Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

T-DM1 and Palbociclib for Metastatic HER2 Breast CancerCompleted
NCT03530696Phase 2Updated Aug 13, 2024
Sponsor: University of Arizona
HER2-positive Breast Cancer · Breast Cancer · Breast Cancer Stage · Recurrent Breast Cancer
United States
Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of DepressionCompleted
NCT00200902Phase 4Updated Aug 13, 2024
Sponsor: University of California, Los Angeles
Depression
United States
A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular AlterationsCompleted
NCT01970865Phase 1, Phase 2Updated Aug 12, 2024
Sponsor: Pfizer
ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC
United States, Australia, Belgium, Canada, France +9 more
Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled SyringeCompleted
NCT05194579Phase 1Updated Aug 12, 2024
Sponsor: Pfizer
Healthy Volunteers
United States
Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes MellitusCompleted
NCT05158244Phase 1Updated Aug 12, 2024
Sponsor: Pfizer
Type 2 Diabetes Mellitus
United States
Gabapentin in Phantom and Stump PainCompleted
NCT00169013Phase 4Updated Aug 9, 2024
Sponsor: Danish Pain Research Center
Amputation of Lower Limb
Denmark
Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)Completed
NCT02679170N/AUpdated Aug 9, 2024
Sponsor: Pfizer
Non-Small Cell Lung Cancer
Spain
Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple MyelomaNo Longer Available
NCT05462639N/AUpdated Aug 9, 2024
Sponsor: Pfizer
Multiple Myeloma
United States, Canada
Voxelotor Brain Oxygenation and Neurocognitive StudyWithdrawn
NCT05228821Phase 4Updated Aug 9, 2024
Sponsor: Pfizer
Sickle Cell Disease
United States
SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)Terminated
NCT03050554Phase 1, Phase 2Updated Aug 9, 2024
Sponsor: Andrew Sharabi
Early Stage Non-Small Cell Lung Cancer
United States
A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or ObeseCompleted
NCT05677867Phase 1Updated Aug 9, 2024
Sponsor: Pfizer
Overweight · Obesity
United States
Study of RSVpreF Vaccination and RSV Challenge in Healthy AdultsCompleted
NCT04785612Phase 2Updated Aug 7, 2024
Sponsor: Hvivo
Respiratory Syncytial Virus Infections
United Kingdom
A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese OriginCompleted
NCT06327880Phase 1Updated Aug 5, 2024
Sponsor: Pfizer
Healthy
Belgium
A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.Completed
NCT05745142N/AUpdated Aug 5, 2024
Sponsor: Pfizer
Carcinoma, Renal Cell · Clear-cell Metastatic Renal Cell Carcinoma
Turkey (Türkiye)
Instrumented Data Exchange for Ataxia StudyCompleted
NCT04268147N/AUpdated Aug 5, 2024
Sponsor: University of Chicago
Spinocerebellar Ataxia Type 1 · Spinocerebellar Ataxia Type 2 · Spinocerebellar Ataxia Type 3 · Spinocerebellar Ataxia Type 6
United States
Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With ObesityTerminated
NCT05579977Phase 2Updated Aug 1, 2024
Sponsor: Pfizer
Diabetes Mellitus · Obesity
United States, Bulgaria, Canada, Czechia, Hungary +3 more
A Study in Healthy Adult Male Participants to Assess Absorption, Distribution, Metabolism and Excretion (ADME) of Radiolabeled PF-06865571.Completed
NCT04866225Phase 1Updated Jul 31, 2024
Sponsor: Pfizer
Healthy Participants
United States
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)Terminated
NCT02554812Phase 1, Phase 2Updated Jul 30, 2024
Sponsor: Pfizer
Advanced Cancer
United States, Australia, Canada, France, Japan +3 more
A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to AdultsCompleted
NCT05831124Phase 1Updated Jul 29, 2024
Sponsor: Pfizer
Pneumococcal Disease
United States
Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid TumorsTerminated
NCT04628780Phase 1Updated Jul 29, 2024
Sponsor: Pfizer
Non-small-cell Lung Cancer · Squamous Cell Carcinoma of the Head and Neck · Renal Cell Carcinoma · Urothelial Carcinoma
United States
A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy AdultsCompleted
NCT05652660Phase 1Updated Jul 26, 2024
Sponsor: Pfizer
Healthy
United States
Collaborative cOMMUNIty Care for Metastatic breAsT cancEr Patients in inDonesia (Communicated)Unknown
NCT06517992NAUpdated Jul 24, 2024
Sponsor: Gadjah Mada University
Metastatic Breast Cancer · Cancer
Indonesia
Southeast Netherlands Advanced Metastatic Breast Cancer RegistryRecruiting
NCT03577197N/AUpdated Jul 23, 2024
Sponsor: Academisch Ziekenhuis Maastricht
Advanced Breast Cancer · Metastatic Breast Cancer
Netherlands
A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Cancer.Completed
NCT05770713N/AUpdated Jul 22, 2024
Sponsor: Pfizer
Breast Cancer
Canada
Safety and Efficacy Active Drug vs. Placebo in Subjects With AsthmaTerminated
NCT04987944Phase 1Updated Jul 19, 2024
Sponsor: Pfizer
Asthma
Canada

Previous page Next page